| dc.description.sponsorship | Tim Spelman received honoraria for consultancy, funding for travel and compensation for serving on scientific advisory boards from Biogen and speaker honoraria from Novartis.; Dana Horakova received speaker honoraria and consulting fees from Biogen, Merck, Teva and Novartis; support for research activities from Biogen; research grants from Charles University in Prague.; Eva Havrdova received speaker honoraria and consultant fees from Actelion, Biogen, Celgene, Merck, Novartis, Roche, Sanofi and Teva support for research activities from Czech Ministry of Education.; Maria Trojano received speaker honoraria from Biogen-Idec, Bayer-Schering, Sanofi Aventis, Merck, Teva, Novartis and Almirall; received research grants for her Institution from Biogen-Idec, Merck Novartis.; Marc Girard received consulting fees from Teva Canada, Biogen, Novartis and Genzyme Sanofi; lecture payments from Teva Canada, Novartis and EMD; received a research grant from CIHR. Pierre Duquette served on editorial boards and was supported to attend meetings by EMD, Biogen, Novartis, Genzyme and TEVA; holds grants from the CIHR and the MS Society of Canada; received funding for investigator-initiated trials from Biogen, Novartis Genzyme.; Alessandra Lugaresi is a Bayer, Biogen, Genzyme, Merck Advisory Board Member. She received travel grants and honoraria from Bayer, Biogen, Merck, Novartis, Sanofi, Teva and FISM. Her institution received research grants from Bayer, Biogen, Merck, Novartis, Sanofi, Teva and FISM.; Francois Grand Maison received honoraria or research funding from Biogen, Genzyme, Novartis, Teva, Mitsubishi and ONO Pharmaceuticals.; Pierre Grammond is a Merck, Novartis, Teva, Biogen and Genzyme advisory board member, consultant for Merck; received payments for lectures by Merck, Teva and Canadian Multiple sclerosis society; received grants for travel from Teva and Novartis. Patrizia Sola served on scientific advisory boards for Biogen Idec and TEVA; received funding for travel and speaker honoraria from Biogen Idec, Merck, Teva, Sanofi Genzyme, Novartis and Bayer and research grants for her Institution from Bayer, Biogen, Merck, Novartis, Sanofi, Teva.; Murat Terzi received travel grants from Merck, Novartis, Bayer-Schering, Merck and Teva; participated in clinical trials by Sanofi Aventis, Roche and Novartis.; Eugenio Pucci served on scientific advisory boards for Merck, Genzyme and Biogen; received honoraria and travel grants from Sanofi Aventis, UCB, Lundbeck, Novartis, Bayer Schering, Biogen, Merck, Genzyme and Teva; received travel grants and equipment from "Associazione Marchigiana Sclerosi Multipla e altre malattie neurologiche".; Franco Granella served on scientific advisory boards for Biogen Idec, Novartis and Sanofi Aventis and received funding for travel and speaker honoraria from Biogen Idec, Merck Almirall.; Cristina Ramo received research funding, compensation for travel or speaker honoraria from Biogen, Novartis, Genzyme and Almirall. | en_US |
